Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1344609

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Accident and Emergency Departments: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the increase in the number of children presenting at A&E with infections on A&E waiting times.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	29180
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The Department continues to monitor data on accident and emergency (A&amp;E) waiting time standards.</p><p> </p><p>The National Health Service plans for a wide range of scenarios ahead of winter and will continue to adapt plans in line with any further advice from Public Health England.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 12/07/2021 16:39:10 answering member 4362 label Biography information for Edward Argar
tabling member	4811 label Biography information for Navendu Mishra

1344635

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the covid-19 transmission rates for people who have had (a) one vaccine and (b) two vaccines for each of the different vaccines.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29085
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The following table shows the latest summary of evidence on vaccine effectiveness against different outcomes, including transmission, for Pfizer/BioNTech and University of Oxford/AstraZeneca as of 1 July 2021.</p><p> </p><table><tbody><tr><td rowspan="3"><p>Outcome</p></td><td colspan="4"><p>Vaccine Effectiveness</p></td></tr><tr><td colspan="2"><p>Pfizer/BioNTech</p></td><td colspan="2"><p>Oxford/AstraZeneca</p></td></tr><tr><td><p>1 dose</p></td><td><p>2 doses</p></td><td><p>1 dose</p></td><td><p>2 doses</p></td></tr><tr><td><p>Symptomatic disease</p></td><td><p>55-70%*</p></td><td><p>85-95%*</p></td><td><p>55-70%*</p></td><td><p>70-85%**</p></td></tr><tr><td><p>Hospitalisation</p></td><td><p>75-85%*</p></td><td><p>90-99%**</p></td><td><p>75-85%*</p></td><td><p>80-99%***</p></td></tr><tr><td><p>Mortality</p></td><td><p>70-80%**</p></td><td><p>95-99%**</p></td><td><p>75-85%**</p></td><td><p>75-99%***</p></td></tr><tr><td><p>Infection</p></td><td><p>55-70%**</p></td><td><p>70-90%***</p></td><td><p>60-70%***</p></td><td><p>No data</p></td></tr><tr><td><p>Transmission (secondary cases)^</p></td><td><p>45-50%***</p></td><td><p>No data</p></td><td><p>35-50%***</p></td><td><p>No data</p></td></tr></tbody></table><p> </p><p>Source: Table 3, <a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fcovid-19-vaccine-surveillance-report&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cb2598e32058644d021bf08d916c0fea2%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637565840415583246%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=MFmH8qQxqsBUGSNXnO5e7tyCyPWBtYpuq%2FF3GUfu6AI%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report</a></p><p> </p><p>Notes:</p><ol><li>*High Confidence - Evidence from multiple studies which is consistent and comprehensive.</li><li>**Medium Confidence - Evidence is emerging from a limited number of studies or with a moderately level of uncertainty.</li><li>***Low Confidence - Little evidence is available at present and results are inconclusive.</li><li>^effectiveness in reducing symptomatic secondary cases in households of a symptomatic index case.</li></ol><p> </p><p>Public Health England plans to publish vaccine effectiveness data for Moderna when more evidence becomes available.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 15:50:18 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344764

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the covid-19 outbreak on average waiting times for NHS paediatric dermatology services in (a) Coventry, (b) the West Midlands and (c) England; and what steps his Department is taking to tackle the backlogs for those services in those areas.
tabling member constituency	Coventry North East
tabling member printed	Colleen Fletcher
uin	29067
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>There has been no formal assessment.</p><p>The Department is taking steps to tackle the backlogs and long waiting times as a priority, across all elective healthcare services. This includes £1 billion for National Health Service systems across the country to increase activity and tackle backlogs. It also includes encouraging innovation, as seen in the NHS’s accelerator programme, including extra clinics at weekends and virtual assessments at home. This type of innovation will help develop a blueprint for elective recovery across all services.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 12/07/2021 16:36:06 answering member 4362 label Biography information for Edward Argar
tabling member	4378 label Biography information for Colleen Fletcher

1344767

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his officials are having with their counterparts in the European Commission on potential travel restrictions for UK citizens who have had the AstraZeneca vaccine produced by the Serum Institute of India.
tabling member constituency	South Shields
tabling member printed	Mrs Emma Lewell-Buck
uin	29059
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The Government continues to engage the European Union on certification to ensure that travel between the United Kingdom and the EU is unhindered and supported by a common approach.</p><p>The Serum Institute of India (SII) manufactures Vaxzevria and Covishield and both branded vaccines are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised Vaxzevria vaccine and it is therefore recognised by the EU.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 16:51:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4277 label Biography information for Mrs Emma Lewell-Buck

1344819

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish data on the number of pregnant and breastfeeding women who have had covid-19 vaccinations.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	29137
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The data is not held centrally in the format requested.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 15:52:52 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4676 label Biography information for Marsha De Cordova

1344847

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the enquiry of 11 March 2021 from the hon. Member for High Peak, referenced RL17500.
tabling member constituency	High Peak
tabling member printed	Robert Largan
uin	29163
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>We replied to the hon. Member on 2 July 2021.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 12/07/2021 11:17:16 answering member 4362 label Biography information for Edward Argar
tabling member	4852 label Biography information for Robert Largan

1344848

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the enquiry of 13 April 2021 from the hon. Member for High Peak, referenced RL21590.
tabling member constituency	High Peak
tabling member printed	Robert Largan
uin	29164
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>We replied to the hon. Member on 28 June 2021.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 12/07/2021 11:20:49 answering member 4362 label Biography information for Edward Argar
tabling member	4852 label Biography information for Robert Largan

1344850

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the enquiry of 14 May 2021 from the hon. Member for High Peak, referenced RL21940.
tabling member constituency	High Peak
tabling member printed	Robert Largan
uin	29166
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>We replied to the hon. Member on 8 July 2021.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 12/07/2021 11:22:04 answering member 4362 label Biography information for Edward Argar
tabling member	4852 label Biography information for Robert Largan